Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

ABSTRACT: A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

PROVIDER: PRJNA422201 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6371170_1.fastq.gz	Fastqsanger.gz
	SRR6371170_2.fastq.gz	Fastqsanger.gz
	SRR6371180_1.fastq.gz	Fastqsanger.gz
	SRR6371180_2.fastq.gz	Fastqsanger.gz
	SRR6371190_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [array]

Project description:A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [array]

| PRJNA420193 | ENA

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [RNA-Seq]

Project description:A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [RNA-Seq]

| PRJNA422203 | ENA

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-12-13 | GSE108004 | GEO

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [array]

Project description:We demonstrate a promising approach to identify robust molecular markers for targeted treatment of acute myeloid leukemia. We show that our method outperforms several state-of-the-art approaches in identifying molecular markers replicated in validation data and predicting drug sensitivity accurately. Finally, we identify SMARCA4 as a marker and driver of sensitivity to topoisomerase II inhibitors, mitoxantrone and etoposide, in AML by showing that cell lines transduced to have high SMARCA4 expression reveal dramatically increased sensitivity to these agents.

2017-11-30 | GSE107465 | GEO

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia [RNA-Seq]

2017-12-13 | GSE108003 | GEO

Precision Medicine for Inherited Retinal Degenerations

Project description:Precision Medicine for Inherited Retinal Degenerations

| PRJNA736120 | ENA

Precision Medicine for Inherited Retinal Degenerations

Project description:Precision Medicine for Inherited Retinal Degenerations

| PRJNA736121 | ENA

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.

Project description:Cancers that appear pathologically similar often respond differently to the same drug regimens. Methods to better match patients to drugs are in high demand. We demonstrate a promising approach to identify robust molecular markers for targeted treatment of acute myeloid leukemia (AML) by introducing: data from 30 AML patients including genome-wide gene expression profiles and in vitro sensitivity to 160 chemotherapy drugs, a computational method to identify reliable gene expression markers for drug sensitivity by incorporating multi-omic prior information relevant to each gene's potential to drive cancer. We show that our method outperforms several state-of-the-art approaches in identifying molecular markers replicated in validation data and predicting drug sensitivity accurately. Finally, we identify SMARCA4 as a marker and driver of sensitivity to topoisomerase II inhibitors, mitoxantrone, and etoposide, in AML by showing that cell lines transduced to have high SMARCA4 expression reveal dramatically increased sensitivity to these agents.

| S-EPMC5752671 | biostudies-literature

The Brazilian Initiative on Precision Medicine (BIPMed)

Project description:The development of precision medicine strategies requires prior knowledge of the genetic background of the target population. However, despite the availability of data from admixed Americans within large reference population databases, we cannot use these data as a surrogate for that of the Brazilian population. This lack of transferability is mainly due to differences between ancestry proportions of Brazilian and other admixed American populations. To address the issue, a coalition of research centres created the Brazilian Initiative on Precision Medicine (BIPMed), an initiative of five Research Innovation and Dissemination Centers (RIDCs) supported by FAPESP.

2020-08-22 | GSE156652 | GEO

Precision medicine for ABCA4 disease: modifier alleles

Project description:Precision medicine for ABCA4 disease: modifier alleles

| PRJNA717338 | ENA